Luolifen Holdings Co., Ltd. (Company Code: 6666), operating in the Biotechnology and Medical Industry, announced its Q4 2025 financial results. The company reported a basic earnings per share of NTD 2.42, with operating revenue reaching NTD 1.113 billion and net income after tax at NTD 108 million.
Company Code: 6666. Company Name: Luolifen Holdings Co., Ltd. Industry: Biotechnology and Medical Industry. Year/Quarter: 2025 Q4. Basic Earnings Per Share: NTD 2.42. Operating Revenue: NTD 1.113 billion. Net Income After Tax: NTD 108 million.
FACT BOX
- Source: PR Times
- Category: 其他